SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

752

Vertex Pharmaceuticals

VRTX

Looking for leads, investment insights, or competitive intelligence?

CEO

Jeffrey M. Leiden

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Boston, Mass.

Years on Fortune 500 List

-

Employees

2,500

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$3,047.622.5%
Profits ($M)$2,096.9695.8%
Assets ($M)$6,245.9
Total Stockholder Equity ($M)$4,435.2
Profit Ratios
Profit as % of Revenues68.8%
Profits as % of Assets33.6%
Profits as % of Stockholder Equity47.3%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)8.09
EPS % Change (from 2017)677.9%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2018)10.6%
Total Return to Investors (5 year, annualized)17.4%
Total Return to Investors (10 year, annualized)18.5%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Vertex Pharmaceuticals

The 5 Best Biotech and Health Care Stocks to Buy for 2019 Now That Congress Can’t Repeal Obamacare

With Congress split between Republicans and Democrats, pharma and biotech stocks are ready to surge.

Read More →
These Are the Health Care Companies Poised for Explosive Growth

From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.

Read More →
The Best Investing Advice for 2018 From Fortune’s Experts

Insights from our annual roundtable on the best stocks and the biggest risks.

Read More →
Nasdaq and S&P Reach New Highs Powered by Tech Stocks

IBM dragged, serving as a tech stock outlier. Energy and health sectors advanced.

Read More →